Dai Lu Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2019

Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate β-Arrestin-Dependent Responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dai Lu Research Topics

Disease

3	Neoplasms (Cancer) 11/2022 - 12/2018
3	Pain (Aches) 01/2022 - 03/2013
3	Obesity 01/2019 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 12/2018
2	Catalepsy 01/2020 - 05/2005
2	Hypothermia 01/2020 - 05/2005
2	Alzheimer Disease (Alzheimer's Disease) 05/2016 - 05/2016
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Neuroblastoma 11/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Diarrhea 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Colonic Neoplasms (Colon Cancer) 02/2021
1	Neuralgia (Stump Neuralgia) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Leukemia 12/2018
1	Acute Promyelocytic Leukemia 12/2018
1	Abdominal Obesity 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 04/2014
1	Substance-Related Disorders (Drug Abuse) 03/2013
1	Feeding and Eating Disorders (Eating Disorder) 03/2013
1	Atherosclerosis 01/2006
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2006
1	Asthma (Bronchial Asthma) 01/2006
1	Multiple Sclerosis 01/2006
1	Rheumatoid Arthritis 01/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2006

Drug/Important Bio-Agent (IBA)

4	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022 - 03/2013
3	CannabinoidsIBA 01/2022 - 03/2013
2	Cytotoxins (Cytolysins)IBA 02/2021 - 12/2018
2	Appetite Depressants (Anorectics)IBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 05/2016
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 05/2016 - 05/2016
2	Amyloid (Amyloid Fibrils)IBA 05/2016 - 05/2016
2	EndocannabinoidsIBA 01/2016 - 01/2006
1	cemiplimabIBA 01/2023
1	camrelizumabIBA 01/2023
1	pembrolizumabIBA 01/2023
1	IpilimumabIBA 01/2023
1	NivolumabIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	LigandsIBA 01/2023
1	ulixertinibIBA 11/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	AntidiarrhealsIBA 01/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Naloxone (Narcan)FDA LinkGeneric 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 02/2021
1	anandamide (arachidonylethanolamide)IBA 01/2020
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 01/2020
1	ArsenicIBA 12/2018
1	CarbohydratesIBA 12/2018
1	Arsenic Trioxide (Trisenox)FDA Link 12/2018
1	Retinoic Acid Receptor alphaIBA 12/2018
1	oxophenarsineIBA 12/2018
1	acetylaminophenylarsine oxideIBA 12/2018
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2017
1	RimonabantIBA 01/2017
1	Peptides (Polypeptides)IBA 05/2016
1	Peptide Hydrolases (Proteases)FDA Link 05/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2014
1	SodiumIBA 04/2014
1	CyclodextrinsIBA 04/2014

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2016
1	Drug Therapy (Chemotherapy) 01/2023
1	Analgesia 05/2005